Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1539-1545

  Li, Tao ^a   Huang, Shengsong ^a   Dong, Minghua ^b   Gui, Yaping ^a   Wu, Denglong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Biochemical recurrence; Immunohistochemistry; Prostate cancer; Radical prostatectomy; SUMO specific protease 1; Tissue microarray

Indexed keywords

CELL PROTEIN; MESSENGER RNA; SENP1 PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL IMMORTALIZATION; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION;

BIOCHEMICAL RECURRENCE; IMMUNOHISTOCHEMISTRY; PROSTATE CANCER; RADICAL PROSTATECTOMY; SUMO-SPECIFIC PROTEASE 1; TISSUE MICROARRAY;

AGED; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 84886296135     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.03.007     Document Type: Article

References (29)

1. Siegel R., Ward E., Brawley O., et al. Cancer statistics. CA Cancer J Clin 2011, 2011:212-236.
2. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 6:69-90.
3. Zhang L., Wu S., Guo L.R., et al. Diagnostic strategies and the incidence of prostate cancer: Reasons for the low reported incidence of prostate cancer in China. Asian J Androl 2009, 11:9-13.
4. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 2002, 360:1131-1135.
5. Molitierno J., Evans A., Mohler J.L., et al. Characterization of biochemical recurrence after radical prostatectomy. Urol Int 2006, 77:130-134.
6. Lapointe J., Li C., Higgins J.P., et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004, 101:811-816.
7. Zhou L.X., Li T., Huang Y.R., et al. Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy. Asian J Androl 2010, 12:171-179.
8. Hay R.T. SUMO: A history of modification. Mol Cell 2005, 18:1-12.
9. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol 2007, 8:947-956.
10. Sentis S., le Romancer M., Bianchin C., et al. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 2005, 19:2671-2684.
11. Yamashita D., Yamaguchi T., Shimizu M., et al. The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain. Genes Cells 2004, 9:1017-1029.
12. Johnson E.S. Protein modification by SUMO. Annu Rev Biochem 2004, 73:355-382.
13. Mukhopadhyay D., Dasso M. Modification in reverse: The SUMO proteases. Trends Biochem Sci 2007, 32:286-295.
14. Yeh E.T. Sumoylation and de-sumoylation: Wrestling with life's processes. J Biol Chem 2009, 284:8223-8227.
15. Gong L., Millas S., Maul G.G., et al. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 2000, 275:3355-3359.
16. Cheng J., Kang X., Zhang S., et al. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007, 131:584-595.
17. Bawa-Khalfe T., Yeh E.T. SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression. Genes. Cancer 2010, 1:748-752.
18. Bawa-Khalfe T., Cheng J., Lin S.H., et al. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem 2010, 285:25859-25866.
19. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
20. Soumaoro L.T., Uetake H., Higuchi T., et al. Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004, 10:8465-8471.
21. Cheng J., Bawa T., Lee P., et al. Role of desumoylation in the development of prostate cancer. Neoplasia 2006, 8:667-676.
22. Bawa-Khalfe T., Cheng J., Wang Z., et al. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 2007, 282:37341-37349.
23. Scher H.I., Sawyers C.L. Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005, 23:8253-8261.
24. Cheng J., Wang D., Wang Z., et al. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 2004, 24:6021-6028.
25. Cheng J., Perkins N.D., Yeh E.T. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J Biol Chem 2005, 280:14492-14498.
26. Pouysségur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumor regression. Nature 2006, 441:437-443.
27. Shariat S.F., Svatek R.S., Kabbani W., et al. Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. BJU Int 2008, 101:232-237.
28. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999, 281:1591-1597.
29. Kuczyk M.A., Serth J., Bokemeyer C., et al. The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy. Eur J Cancer 1998, 34:679-686.